The upregulation of the P300/CBP complex regulates the expression of oncogenes and tumor suppressors, including those encoding c-MYC, AR, P53, and BRCA1, which are associated with poor prognosis and tumor recurrence in patients with breast cancer [112,113,114,115,116]. Here, CREBBP is linked to breast carcinoma.